Smartwatch ABPM vs. Conventional ABPM (SamsungWatch)

April 5, 2021 updated by: Young Jin Youn, Wonju Severance Christian Hospital

Correlation Between Smartwatch-based Blood Pressure Monitoring and Conventional Ambulatory Blood Pressure Monitoring

This study aims to investigate the accuracy and precision of the Samsung Smartwatch with conventional ambulatory blood pressure monitoring in healthy volunteers.

Study Overview

Detailed Description

Blood pressure (BP) monitoring outside of the medical care environment is an increasingly important part of clinical hypertension assessment and management. Ambulatory BP monitoring (ABPM) uses automatic detection and recording devices for repeated determinations during an extended period, typically 24 hours. This technique has been shown to substantially enhance the clinician's understanding of BP behavior in patients and aid in diagnosis and therapeutic decision making. The ABPM is superior to office BP in predicting target organ, hypertensive cerebrovascular disease, retinopathy, renal abnormalities, and alterations in vascular compliance.1-4) Most of these studies have also demonstrated that a loss of nocturnal decline in BP (so-called non-dipper) conveys excessive risk for stroke and myocardial infarction.

Although conventional ABMP is usually well tolerated by patients, a few problems do exist. A minority of patients do not sleep well with the recorders and tend to have somewhat higher BP values. Cuffs can also rotate, and different arm positions can change BP significantly. Rarely, patients may develop erythema, ecchymoses, petechiae, or superficial phlebitis in the area distal to cuff placement.

Recently, smartwatches that measure BP without a cuff have become available. Since these measurements are relatively more user-friendly than conventional cuff-based measurements, they may aid in more frequent BP monitoring. Currently, only one study compared a non-commercial armband wearable pulse transit time (PTT) system for 24-hour cuff-less BP measurement with ABPM.5) We will investigate the accuracy and precision of Samsung Smartwatch with ABPM in young, healthy volunteers.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gangwon-do
      • Wonju, Gangwon-do, Korea, Republic of, 26426
        • Wonju Severance Christian Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy subjects willing to participate in this trial

Description

Inclusion criteria

  • Ambulatory healthy subjects
  • Subjects aged 20 years or more
  • Subjects willing to participate in this study voluntarily Exclusion criteria
  • Subjects inability to provide informed consent
  • Subjects with any medical history
  • Subjects with irregular heart rhythm (e.g. atrial fibrillation, atrial flutter, or bigeminy)
  • Subjects unable to wear a watch due to wrist circumference
  • Subjects with BP difference 10mmHg or more between left and right arm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy subjects
Healthy subjects without blood pressure difference on both arm
Every 30 minutes from 7 AM to 10 PM and every 1 hour from 10 PM to 7 AM
Every 1 hour by subject (on-demand) from 7 AM to 10 PM and every 5 minutes (automatic) from 10 PM to 7 AM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean nighttime blood pressure
Time Frame: Baseline
Correlation of mean nighttime BP between the ABPM and the BP using the smartwatch
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Every time point blood pressure
Time Frame: Baseline
BP differences between the ABPM and the BP using the smartwatch at every time point of measurement
Baseline
Mean 24-hour blood pressure
Time Frame: Baseline
Correlation of mean 24-h BP between the ABPM and the BP using the smartwatch
Baseline
Mean daytime blood pressure
Time Frame: Baseline
Correlation of mean daytime BP between the ABPM and the BP using the smartwatch
Baseline
Nighttime dipping
Time Frame: Baseline
Correlation of nighttime dipping between the ABPM and the BP using the smartwatch
Baseline
Morning blood pressure
Time Frame: Baseline
Correlation of morning BP between the ABPM and the BP using the smartwatch
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Young Jin Youn, MD, PhD, Wonju Severance Christian Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

September 11, 2020

First Submitted That Met QC Criteria

September 11, 2020

First Posted (Actual)

September 18, 2020

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 5, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • SamsungWatch

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Ambulatory blood pressure monitoring

3
Subscribe